John Matthew Pierce in Bessemer, Alabama

Home Alabama Bessemer

John Matthew Pierce has Internal Medicine as his primary medical specialty. Their primary office is: 737 Memorial Dr in Bessemer, Alabama.

They're a part of the: Birmingham Hematology Oncology Assoc Llc medical group which has around 28 members. You can call their office at 205-481-4511 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Louisville School Of Medicine and graduated in 2010 (around 14 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

John Matthew R Pierce Office Phone and Directions

John Matthew Pierce
Birmingham Hematology Oncology Assoc Llc
737 Memorial Dr
Bessemer, Alabama 35022
205-481-4511

Patient Ratings
Please rate your experience with John Matthew Pierce below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 205-481-4511

Enter a starting address:

Healthcare Info for John Matthew Pierce

Medical School: University Of Louisville School Of Medicine
Graduation Year: 2010
The Primary Medical Specialty for John Matthew Pierce is listed as: Internal Medicine
Approximate Years of Experience: 14
PAC (PECOS ID)#: 2668619438
NPI #: 1669799961
NPI Created On: 04/26/2010
NPI Last Updated Listed as: 04/08/2019
Primary Taxonomy Code: 207RH0003X
License Number:
31405
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Complete blood cell count (red cells, white blood cell, platelets), automated test
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Application of on-body injector for injection under skin
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 15 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788546883

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818574227

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818578899

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832187503

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832187511

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832187531

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ADCETRIS

Open Associated Drug #1: 51144-050-01

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832187583

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ADCETRIS

Open Associated Drug #1: 51144-050-01

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832187709

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60

Payments Total: $16

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783673963

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Hematology

Name of Drug #1: REBLOZYL

Open Associated Drug #1: 59572-711-01

Payments Total: $13

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783673965

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ABECMA

Open Associated Drug #1: 59572-515-01

Internal Medicine Professionals in Bessemer

1.
Benjamin Broome

995 9th Ave Sw
Bessemer, AL
Nephrology Associates, Pc

2.
Wallace Purdy JR. MD

1088 9th Ave Sw
Bessemer, AL
West Jefferson Internal Medicine Pc

3.
Michael Moore MD

995 9th Ave Sw
Bessemer, AL
Medical West Hospital Authority, An Affiliate Of Uab Health System

4.
Michael Moore MD

927 Medical Ctr Dr
Bessemer, AL
Medical West Hospital Authority, An Affiliate Of Uab Health System

5.
Michael Moore MD

985 9th Ave Sw
Bessemer, AL
Medical West Hospital Authority, An Affiliate Of Uab Health System

6.
Harini Doppalapudi MD

950 Medical Ctr Dr
Bessemer, AL
Medical West Hospital Authority, An Affiliate Of Uab Health System

Providers in Birmingham Hematology Oncology Assoc Llc

1.Brian Adler Md

2022 Brookwood Med Ctr
Birmingham Al 35213-1966
Birmingham Hematology Oncology Assoc Llc
Hematology/oncology

2.Daniel Allendorf

1024 1st St N
Alabaster Al 35007-8703
Birmingham Hematology Oncology Assoc Llc
Medical Oncology

3.Stephen Beck

737 Memorial Dr
Bessemer Al 35022-6029
Birmingham Hematology Oncology Assoc Llc
Medical Oncology

4.Stephen Beck

2728 10th S Ave
Birmingham Al 35205-1202
Birmingham Hematology Oncology Assoc Llc
Medical Oncology

5.Stephen Beck

810 Saint Vincents Dr
Birmingham Al 35205-1601
Birmingham Hematology Oncology Assoc Llc
Medical Oncology

6.Cara Bondly Md

737 Memorial Dr
Bessemer Al 35022-6029
Birmingham Hematology Oncology Assoc Llc
Hematology/oncology

View all 28 members of Birmingham Hematology Oncology Assoc Llc medical group